Search Weight Loss Topics:

Home » Long Term Weight Loss » FDA Recalls Weight Loss Pill Belviq Due To Increased Cancer Risk – International Business Times

KEY POINTS

Obesity is a chronic health condition that affects more than one in three Americans. Some individuals struggling with weight issues might not get benefited from regular physical activity and a healthy eating plan alone and their doctors might prescribe medications as part of their weight-control program. The U.S. FDA had approved orlistat (Xenical, Alli), lorcaserin (Belviq), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), and liraglutide (Saxenda) for long-term use.

But, following the results of a recent safety trial, the FDA has issued a warning that lorcaserin (Belviq) might increase ones risk of cancer. Pharmaceutical company Eisai has voluntarily withdrawn the weight loss pill from the market.

Such a decision has been taken after the FDA issued a warning against Belviq that it hadnt passed a recent safety trial and that the drug could increase an individuals risk of cancer.

The potential cancer risk outweighs the benefits

Lorcaserin is a previously FDA-approved weight loss supplement designed to treat obesity and overweight-related health issues. The drug suppresses an individuals sense of hunger. But, a recently updated statement from the FDA conveyed that, when they initially approved the drug in 2012, they required the drug manufacturer to conduct a clinical trial to evaluate the risk of heart diseases. Post this clinical safety trial, the FDA reported that the drug was not only unsafe but could possibly make people using it more likely to develop certain forms of cancer.

A range of cancer types including pancreatic, colorectal, and lung cancers were associated with lorcaserin use. Healthcare professionals are advised to stop prescribing Belviq and to immediately contact everyone who might be using the pill and inform them about the potential risk of cancer.

How to dispose these unsafe drugs?

The FDA advises individuals who already are in possession of Belviq tablets to safely dispose them.Heres what they recommend:

A new prescription weight loss pill has some health officials hopeful. Photo: Pixabay

More here:
FDA Recalls Weight Loss Pill Belviq Due To Increased Cancer Risk - International Business Times

Your Full Name
Your Email
Your Phone Number
Select your age (30+ only)	30313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120
Select Your US State	Select Your StateAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington,DCWest VirginiaWisconsinWyoming
Program Choice	Select Your ProgramInjectable HGHInjectable TestoteroneInjectable SermorelinInjectable Weight LossInjectable HCG DietInjectable Vitamins
Confirm over 30 years old	Yes
Confirm that you resident in USA	Yes
This is a Serious Inquiry	Yes
Message:

Home » Long Term Weight Loss » FDA Recalls Weight Loss Pill Belviq Due To Increased Cancer Risk – International Business Times